欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
抑郁症严重危害人类身心健康，世界卫生组织预测到2020年抑郁症将成为非正常死亡和残疾的第二大原因。目前抑郁症仍以药物为主治疗，但已上市抗抑郁药并不理想，因此开发疗效更高、特点明显、不良反应更少的新型抗抑郁药物是新药研发者追求的目标。该文归纳总结了目前已上市、处于新药研发及新药发现阶段的抗抑郁中药及天然药物，旨在为抗抑郁新药研发提供参考。
英文摘要：
Depression becomes more and more serious and has been greatly do harm to human＇s physical and mental health. WHO predicts that depression will become the second leading cause of abnormal death and disability by 2020. There is still the drug treatment as the first-line antidepressive therapy, but the effect of listed antidepressant drugs is not ideal Therefore, discovery of new antidepres- sant drug of sunique, higher curative effect, less adverse reaction is the pursuit of pharmaceutical. The traditional Chinese medicine （TCM） of anti-depression and natural antidepressant in currently listed, drug development and drug discovery phase are summarized in this paper, aiming to provide reference for new antidepressant drug research.
同期刊论文项目
同项目期刊论文
1H-NMR-Based Metabonomic Studies on the Anti-Depressant Effect of Genipin in the ChronicUnpredictabl
H-1 NMR-based metabolic profiling of liver in chronic unpredictable mild stress rats with genipin tr
Investigation on the antidepressant effect of sea buckthorn seed oil through the GC-MS-based metabol
1 H-NMR-Based Metabonomic Studies on the Anti-Depressant Effect of Genipin in the Chronic Unpredicta
Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional C
Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoya
期刊信息
位置：